Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

EU approves Roche’s Cotellic in combo therapy against skin cancer

Written by: | no-reply@reuters.com | Dated: Wednesday, November 25th, 2015

 

Roche is counting on Cotellic to help it revive flagging sales of five-year-old Zelboraf, which dropped 25 percent during the first nine months of 2015. It has been under intense pressure from rivals’ drugs as the standard of care moves to combination therapy.

The Food and Drug Administration approved the Cotellic-Zelboraf combination in the United States earlier this month, with approval from Switzerland in August.

 

(Reporting by John Miller)

Source: Reuters Health

http://www.reuters.com/article/2015/11/25/us-roche-cotellic-idUSKBN0TE1XI20151125

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!

Subscribe

Ad Right Bottom

Main Navigation